Jill R. Cherry-Bukowiec

TL;DR: The AGORA (Antimicrobials: A Global Alliance for Optimizing their Rational Use in Intra-Abdominal Infections) project as discussed by the authors is an international task force from 79 different countries has joined this project by sharing a document on the rational use of antimicrobial therapy for patients with IAIs.

TL;DR: An international multidisciplinary panel of experts from the World Society of Emergency Surgery updated its guidelines for management of CDI in surgical patients according to the most recent available literature, including recent changes introduced in the management of this infection.

TL;DR: In this article, the authors report that patients requiring emergent laparotomy had a 40% mortality rate and no documented evidence of change in outcomes for patients requiring emergency laparotomization.

TL;DR: Preclinical evidence is provided to accelerate the path toward clinical trials targeting BTK and SYK signaling in moderate-to-severe HS, with Bruton’s tyrosine kinase (BTK) and spleen tyrosinase (SYK) pathway activation as a central signal transduction network in HS.

TL;DR: In the last two decades there have been dramatic changes in the epidemiology of Clostridium difficile infection (CDI), with increases in incidence and severity of disease in many countries worldwide as mentioned in this paper.